Recent Updates
Recently added Catalysts
HCA Positive Sentiment

HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group

Thursday, August 6, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: HCA Healthcare has appointed Dr. Michael Schlosser as the new Executive Vice President and Chief Clinical Officer, effective September 1, 2026. Charles Gressle has also been named the President of the newly established Ambulatory Operations Group. These leadership changes are expected to enhance the company's clinical operations and patient care.

Market Sentiment Analysis

POSITIVE FACTORS

  • Appointment of experienced leaders enhances clinical operations.
  • New roles aim to improve patient care and operational efficiency.
  • Strategic leadership changes align with HCA's growth objectives.

Full Press Release Details

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare’s East Florida Division, has been appointed president of HCA Healthcare’s new Ambulatory Operations Group. Dr. Schlosser will succeed Dr. Michael Cuffe, who a

Frequently Asked Questions

Who is the new Chief Clinical Officer at HCA Healthcare?

Dr. Michael Schlosser has been appointed as the Chief Clinical Officer.

When will the new executive appointments take effect?

The appointments will take effect on September 1, 2026.

What is the role of Charles Gressle at HCA Healthcare?

Charles Gressle has been named President of the new Ambulatory Operations Group.

Who did Dr. Schlosser succeed at HCA Healthcare?

Dr. Schlosser will succeed Dr. Michael Cuffe in his new role.

ShareAdd on Google
Tags: HCA Viatris Investor Conferences Healthcare HCA Healthcare Michael Schlosser Charles Gressle executive appointments clinical operations
Last updated: Aug 6, 2026

Biotech snapshot

Cash runway
$1327M liquidity · $0M/mo burn
Low dilution risk